Patent ID: 9447098
Filing Date: 2016-09-20
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A compound selected from the group consisting of a compound of formula (I): a tautomeric form, and stereochemically isomeric form thereof, wherein W is —N(R each R wherein R 17 represents hydrogen or fluorine, p represents 1 or 2 and X represents 0 or S; D represents a 3 to 12 ring membered monocyclic or bicyclic carbocyclyl or a 3 to 12 ring membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O or S, wherein said carbocyclyl and heterocyclyl may each be optionally substituted by one or more R R R —O—C(═O)—C —C(═O)—R —C —S(═O) R R wherein ring A represents a monocyclic 5 to 7 membered saturated heterocyclyl containing one heteroatom selected from N, O or S, said heteroatom not being positioned in alpha position of the double bond, wherein ring A is optionally substituted with cyano, C 1-4 alkyl, hydroxyC 1-4 alkyl, H 2 N—C 1-4 alkyl, (C 1-4 alkyl)NH—C 1-4 alkyl, (C 1-4 alkyl) 2 N—C 1-4 alkyl, (haloC 1-4 alkyl)NH—C 1-4 alkyl, C 1-4 alkoxyC 1-4 alkyl, —C(═O)—NH 2 , —C(═O)—NH(C R R —O—C(═O)—C —C(═O)—R R R C R R C or when two of the substituents of R R haloC R R —C(═O)—C R R —C(═)NR n independently represents 0, 1, 2, 3 or 4; or an N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.